Financhill
Back

Ionis Pharmaceuticals Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
39

IONS
Ionis Pharmaceuticals

Last Price:
38.76
Seasonality Move:
10.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Ionis Pharmaceuticals Price Quote

$38.76
-0.04 (0.89%)
(Updated: November 6, 2024 at 5:14 AM ET)

Ionis Pharmaceuticals Key Stats

Sell
39
Ionis Pharmaceuticals (IONS) is a Sell

Day range:
$37.53 - $39.20
52-week range:
$35.95 - $54.44
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.90
P/B ratio:
23.21%

Volume:
1.3M
Avg. volume:
1.4M
1-year change:
-17.78%
Market cap:
$6.1B
Revenue:
$787.6M
EPS:
$-2.52

How Much Does Ionis Pharmaceuticals Make?

Is Ionis Pharmaceuticals Growing As A Company?

  • What Is Ionis Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.2%
  • What Is Ionis Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Ionis Pharmaceuticals Stock Price Performance

What Is Ionis Pharmaceuticals 52-Week High & Low?

Ionis Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ionis Pharmaceuticals?

Is Ionis Pharmaceuticals Cash Flow Positive?

  • What Is IONS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$346M
  • What Is Ionis Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $34.6M
  • What Is Ionis Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $180.6M

Ionis Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    IONS return on invested capital is -22.52%
  • What Is Ionis Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -12.74%
  • What Is IONS Return On Equity?
    ROE is a measure of profitability and is -108.17%

Ionis Pharmaceuticals Earnings Date & Stock Price

Ionis Pharmaceuticals Competitors

Ionis Pharmaceuticals Dividend Yield

Ionis Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 68.59%
Revenue: 19.55% 50.21%

Analyst Recommendations

Buy Recommendations: 12
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 62.31
Upside from Last Price: 60.59%

Major Shareholders

  • How many IONS shares are owned by institutional investors?
    268.2M IONS shares are owned by institutional investors
  • How many IONS shares are owned by insiders?
    1.4M IONS shares are owned by insiders